CSF1R and non-small cell lung carcinoma: Notably, compared to the currently recognized expression of CD274 gene which encodes for PD-L1, the expression of CSF1R and HCST has been shown to have better efficacy in predicting the response to anti-PD-1 therapy in NSCLC.